These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6306030)
1. A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. Wahren B; Harmenberg J; Sundqvist VA; Levén B; Sköldenberg B J Virol Methods; 1983 Mar; 6(3):141-9. PubMed ID: 6306030 [TBL] [Abstract][Full Text] [Related]
2. Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Rabalais GP; Levin MJ; Berkowitz FE Antimicrob Agents Chemother; 1987 Jun; 31(6):946-8. PubMed ID: 3039912 [TBL] [Abstract][Full Text] [Related]
3. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088 [TBL] [Abstract][Full Text] [Related]
4. A rapid assay to screen for drug-resistant herpes simplex virus. Tebas P; Scholl D; Jollick J; McHarg K; Arens M; Olivo PD J Infect Dis; 1998 Jan; 177(1):217-20. PubMed ID: 9419192 [TBL] [Abstract][Full Text] [Related]
5. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. Harmenberg J; Wahren B; Sundqvist VA; Levén B J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239 [TBL] [Abstract][Full Text] [Related]
6. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398 [TBL] [Abstract][Full Text] [Related]
7. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403 [TBL] [Abstract][Full Text] [Related]
8. Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir. Chutkowski C; Olson B; McDonough A; Mahoney J; McSharry JJ Clin Diagn Lab Immunol; 2002 Nov; 9(6):1379-81. PubMed ID: 12414779 [TBL] [Abstract][Full Text] [Related]
9. Rapid assay of herpes simplex virus sensitivity to drugs. Thornton JE; Smith KO Acta Ophthalmol (Copenh); 1981 Apr; 59(2):259-70. PubMed ID: 6266194 [TBL] [Abstract][Full Text] [Related]
10. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay. Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227 [TBL] [Abstract][Full Text] [Related]
12. A rapid antiviral drug test by enzyme-linked immunoassay. Landini MP; Baldassarri B Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087 [TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Schnitzler P; Schön K; Reichling J Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678 [TBL] [Abstract][Full Text] [Related]
14. Direct measurement of antiviral activities by a novel immunoassay with peroxidase-labeled complement C1q. Taguchi F; Kawasaki T; Lee SM; Yamamoto A J Clin Lab Immunol; 1991 Aug; 35(4):177-81. PubMed ID: 1668854 [TBL] [Abstract][Full Text] [Related]
15. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents. Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991 [TBL] [Abstract][Full Text] [Related]
16. Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus. Piret J; Goyette N; Boivin G J Clin Microbiol; 2016 Aug; 54(8):2120-7. PubMed ID: 27252463 [TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients. Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321 [TBL] [Abstract][Full Text] [Related]
18. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. Langlois M; Allard JP; Nugier F; Aymard M J Biol Stand; 1986 Jul; 14(3):201-11. PubMed ID: 3020058 [TBL] [Abstract][Full Text] [Related]
19. A blinded comparison of two methods of viral susceptibility testing: plaque reduction assay versus microplate in situ ELISA. Leahy BJ; Christiansen KJ; Collins P J Virol Methods; 1996 Jan; 56(1):85-90. PubMed ID: 8690771 [TBL] [Abstract][Full Text] [Related]
20. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples. Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]